ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Company Registration Number:
13787622 (England and Wales)

Unaudited abridged accounts for the year ended 30 June 2024

Period of accounts

Start date: 01 January 2024

End date: 30 June 2024

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Contents of the Financial Statements

for the Period Ended 30 June 2024

Balance sheet
Notes

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Balance sheet

As at 30 June 2024


Notes

6 months to 30 June 2024

2023


£

£
Current assets
Debtors: 3 137 100
Cash at bank and in hand: 2,884 13,683
Total current assets: 3,021 13,783
Creditors: amounts falling due within one year: 4 (2,921) (3,599)
Net current assets (liabilities): 100 10,184
Total assets less current liabilities: 100 10,184
Total net assets (liabilities): 100 10,184
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 99 10,183
Shareholders funds: 100 10,184

The notes form part of these financial statements

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Balance sheet statements

For the year ending 30 June 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 11 October 2024
and signed on behalf of the board by:

Name: Mrs B Rowley
Status: Director

The notes form part of these financial statements

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover is measured at the fair value of the consideration received or receivable in respect of the provision of consultancy services, excluding discounts, rebates, value added tax or other similar sales taxes. The company has not traded during the period under review.

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

2. Employees

6 months to 30 June 2024 2023
Average number of employees during the period 1 1

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

3. Debtors

Debtors comprise of: Trade debtors - £nil (2023 - £100), Other debtors - £137 (2023 - £nil)

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

4. Creditors: amounts falling due within one year note

Taxation and social security - £nil (2023 - £2,475) Other creditors - £2,921 (2023 - £1,124)